Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02652312Completed
Randomised, double-blind trial of dexmedetomidine (2 arms), sponsored by Theodor Bilharz Research Institute. Primary endpoint: desflurane consumption. Started Feb 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02652312.